|
|
|
Volumn 57, Issue 4, 2002, Pages 82-88
|
|
Rheumatoid arthritis: A new treatment;Nouveau traitement de la polyarthrite rhumatoïde
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
ETANERCEPT;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
METHOTREXATE;
MONOCLONAL ANTIBODY;
NONSTEROID ANTIINFLAMMATORY AGENT;
PLACEBO;
TUMOR NECROSIS FACTOR ALPHA;
ADOLESCENT;
ADULT;
ARTHRITIS;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG CONTRAINDICATION;
DRUG HYPERSENSITIVITY;
DRUG INDICATION;
HUMAN;
IMMUNOTHERAPY;
INFECTION;
JUVENILE RHEUMATOID ARTHRITIS;
MAJOR CLINICAL STUDY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
REVIEW;
RHEUMATOID ARTHRITIS;
ADOLESCENT;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, RHEUMATOID;
CHILD;
CHILD, PRESCHOOL;
DRUG INTERACTIONS;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
MALE;
MIDDLE AGED;
RECEPTORS, TUMOR NECROSIS FACTOR;
|
|
EID: 0036630493
PISSN: 00472166
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (0)
|